DEA Places Sedative Into Schedule IV
The Drug Enforcement Administration is placing the newly approved drug remimazolam in Schedule V of the Controlled Substances Act, it said in an interim final rule. Effective Oct. 6, remimazolam, which was granted approval by the Food and Drug Administration…